Women’s health is not a niche – it is the next frontier for better medicine

Women’s health is gaining long-overdue recognition as a critical priority for healthcare, research and innovation. In this blog, Laurence Skillern explores how evolving regulatory priorities, growing FemTech investment and renewed policy focus are creating opportunities to address historical gaps in women’s health research, accelerate innovation and improve patient outcomes. We also consider why collaboration, stronger clinical evidence and sustained investment will be essential to turning this momentum into meaningful progress.